ShareCompartir
Volume 11, Number 3—March 2005
Dispatch
Methicillin-resistant Staphylococcus aureus in Neonatal Intensive Care Unit
Gili Regev-Yochay*†
, Ethan Rubinstein*†, Asher Barzilai*†, Yehuda Carmeli†‡, Jacob Kuint*†, Jerome Etienne§, Mira Blech*, Gill Smollen*, Ayala Maayan-Metzger*†, Azita Leavitt‡, Galia Rahav*†, and Nathan Keller*†
, Ethan Rubinstein*†, Asher Barzilai*†, Yehuda Carmeli†‡, Jacob Kuint*†, Jerome Etienne§, Mira Blech*, Gill Smollen*, Ayala Maayan-Metzger*†, Azita Leavitt‡, Galia Rahav*†, and Nathan Keller*†
Table
Incidence rates of non–multidrug-resistant (MDR) methicillin-resistant Staphylococcus aureus (MRSA) and S. aureus infections: preoutbreak versus outbreak periods*
| Infection | No. infected patients per 1,000 hospitalized patients | p value |
|---|---|---|
| Non-MDR MRSA, preoutbreak period | 1.4 | <0.0001 |
| Non-MDR MRSA, outbreak period | 18.5 | |
| All S. aureus, preoutbreak period | 15.2 | 0.031 |
| All S. aureus, outbreak period | 27.7 | |
| Other S. aureus (methicillin-susceptible and MDR MRSA), preoutbreak period | 13.8 | 0.38 |
| Other S. aureus (methicillin-susceptible and MDR MRSA), outbreak period | 9.2 |
*Preoutbreak period, January 2000–September 2002; outbreak period, October 2002–December 2003.
- Page created: April 25, 2012
- Page last updated: April 25, 2012
- Page last reviewed: April 25, 2012
- Centers for Disease Control and Prevention,
-
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)